
    
      1. To determine the value of using Î²-lactamases inhibitors in reducing the cases of ESBL
           producing E. coli or K. pneumoniae colonization and infection after 12 months.

        2. To compare the acquisition rates of ESBL producing E. coli or K. pneumoniae at MICU1 and
           MICU2 after 12 months
    
  